PreveCeutical Medical Key Fundamental Indicators
| PRVCF Stock | USD 0.02 0.0008 5.59% |
As of the 3rd of February, PreveCeutical Medical holds the Coefficient Of Variation of 896.85, risk adjusted performance of 0.0917, and Semi Deviation of 16.5. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PreveCeutical Medical, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down nineteen technical drivers for PreveCeutical Medical, which can be compared to its competitors. Please check PreveCeutical Medical variance, as well as the relationship between the maximum drawdown and semi variance to decide if PreveCeutical Medical is priced some-what accurately, providing market reflects its current price of 0.0151 per share. As PreveCeutical Medical appears to be a penny stock we also advise to check out its total risk alpha numbers.
PreveCeutical Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PreveCeutical Medical's valuation are provided below:PreveCeutical Medical does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. PreveCeutical |
PreveCeutical Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PreveCeutical Medical's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PreveCeutical Medical.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in PreveCeutical Medical on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding PreveCeutical Medical or generate 0.0% return on investment in PreveCeutical Medical over 90 days. PreveCeutical Medical is related to or competes with Propanc Biopharma,, Telescope Innovations, Cell Source, and ImmunoCellular Therapeutics. PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative... More
PreveCeutical Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PreveCeutical Medical's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PreveCeutical Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 25.05 | |||
| Information Ratio | 0.1106 | |||
| Maximum Drawdown | 476.32 | |||
| Value At Risk | (35.50) | |||
| Potential Upside | 52.12 |
PreveCeutical Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PreveCeutical Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PreveCeutical Medical's standard deviation. In reality, there are many statistical measures that can use PreveCeutical Medical historical prices to predict the future PreveCeutical Medical's volatility.| Risk Adjusted Performance | 0.0917 | |||
| Jensen Alpha | 6.78 | |||
| Total Risk Alpha | 3.07 | |||
| Sortino Ratio | 0.2568 | |||
| Treynor Ratio | (0.92) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PreveCeutical Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PreveCeutical Medical February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0917 | |||
| Market Risk Adjusted Performance | (0.91) | |||
| Mean Deviation | 21.3 | |||
| Semi Deviation | 16.5 | |||
| Downside Deviation | 25.05 | |||
| Coefficient Of Variation | 896.85 | |||
| Standard Deviation | 58.17 | |||
| Variance | 3384.29 | |||
| Information Ratio | 0.1106 | |||
| Jensen Alpha | 6.78 | |||
| Total Risk Alpha | 3.07 | |||
| Sortino Ratio | 0.2568 | |||
| Treynor Ratio | (0.92) | |||
| Maximum Drawdown | 476.32 | |||
| Value At Risk | (35.50) | |||
| Potential Upside | 52.12 | |||
| Downside Variance | 627.63 | |||
| Semi Variance | 272.25 | |||
| Expected Short fall | (36.22) | |||
| Skewness | 6.18 | |||
| Kurtosis | 44.5 |
PreveCeutical Medical Backtested Returns
PreveCeutical Medical is out of control given 3 months investment horizon. PreveCeutical Medical maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11 % return per unit of risk over the last 3 months. We were able to break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 6.49% are justified by taking the suggested risk. Use PreveCeutical Medical Semi Deviation of 16.5, coefficient of variation of 896.85, and Risk Adjusted Performance of 0.0917 to evaluate company specific risk that cannot be diversified away. PreveCeutical Medical holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of -7.04, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning PreveCeutical Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, PreveCeutical Medical is expected to outperform it. Use PreveCeutical Medical jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to analyze future returns on PreveCeutical Medical.
Auto-correlation | -0.15 |
Insignificant reverse predictability
PreveCeutical Medical has insignificant reverse predictability. Overlapping area represents the amount of predictability between PreveCeutical Medical time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PreveCeutical Medical price movement. The serial correlation of -0.15 indicates that less than 15.0% of current PreveCeutical Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, PreveCeutical Medical has a Return On Asset of -3.3124. This is 62.14% lower than that of the Healthcare sector and 85.96% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
PreveCeutical Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PreveCeutical Medical's current stock value. Our valuation model uses many indicators to compare PreveCeutical Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PreveCeutical Medical competition to find correlations between indicators driving PreveCeutical Medical's intrinsic value. More Info.PreveCeutical Medical is rated below average in return on asset category among its peers. It is regarded fifth in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PreveCeutical Medical's earnings, one of the primary drivers of an investment's value.PreveCeutical Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PreveCeutical Medical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of PreveCeutical Medical could also be used in its relative valuation, which is a method of valuing PreveCeutical Medical by comparing valuation metrics of similar companies.PreveCeutical Medical is currently under evaluation in return on asset category among its peers.
PreveCeutical Fundamentals
| Return On Asset | -3.31 | |||
| Current Valuation | 12.06 M | |||
| Shares Outstanding | 523.3 M | |||
| Shares Owned By Insiders | 24.08 % | |||
| Price To Sales | 3,902 X | |||
| Gross Profit | 2.25 K | |||
| EBITDA | (1.28 M) | |||
| Net Income | (1.73 M) | |||
| Cash And Equivalents | 2.64 K | |||
| Total Debt | 1.68 M | |||
| Debt To Equity | 347.60 % | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (426.39 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | 1.08 | |||
| Market Capitalization | 11.93 M | |||
| Total Asset | 161.2 K | |||
| Z Score | -18.9 | |||
| Net Asset | 161.2 K |
About PreveCeutical Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PreveCeutical Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PreveCeutical Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PreveCeutical Medical based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Preveceutical Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in PreveCeutical OTC Stock
PreveCeutical Medical financial ratios help investors to determine whether PreveCeutical OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PreveCeutical with respect to the benefits of owning PreveCeutical Medical security.